Literature DB >> 17511605

Interaction of ceruloplasmin, lactoferrin, and myeloperoxidase.

A V Sokolov1, M O Pulina, K V Ageeva, M I Ayrapetov, M N Berlov, G N Volgin, A G Markov, P K Yablonsky, N I Kolodkin, E T Zakharova, V B Vasilyev.   

Abstract

When lactoferrin (LF) and myeloperoxidase (MPO) are added to ceruloplasmin (CP), a CP-LF-MPO triple complex forms. The complex is formed under physiological conditions, but also in the course of SDS-free PAGE. Polyclonal antibodies to both LF and MPO displace the respective proteins from the CP-LF-MPO complex. Similar replacement is performed by a PACAP38 fragment (amino acids 29-38) and protamine that bind to CP. Interaction of LF and MPO with CP-Sepharose is blocked at ionic strength above 0.3 M NaCl and at pH below 4.1 (LF) and 3.9 (MPO). Two peptides (amino acids 50-109 and 929-1012) were isolated by affinity chromatography from a preparation of CP after its spontaneous proteolytic cleavage. These peptides are able to displace CP from its complexes with LF and MPO. Both human and canine MPO could form a complex when mixed with CP from seven mammalian species. Upon intravenous injection of human MPO into rats, the rat CP-human MPO complex could be detected in plasma. Patients with inflammation were examined and CP-LF, CP-MPO, and CP-LF-MPO complexes were revealed in 80 samples of blood serum and in nine exudates from purulent foci. These complexes were also found in 45 samples of serum and pleural fluid obtained from patients with pleurisies of various etiology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17511605     DOI: 10.1134/s0006297907040074

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  8 in total

Review 1.  The biology of mammalian multi-copper ferroxidases.

Authors:  Sheridan L Helman; Jie Zhou; Brie K Fuqua; Yan Lu; James F Collins; Huijun Chen; Christopher D Vulpe; Gregory J Anderson; David M Frazer
Journal:  Biometals       Date:  2022-02-15       Impact factor: 3.378

2.  Ceruloplasmin is an endogenous inhibitor of myeloperoxidase.

Authors:  Anna L P Chapman; Tessa J Mocatta; Sruti Shiva; Antonia Seidel; Brian Chen; Irada Khalilova; Martina E Paumann-Page; Guy N L Jameson; Christine C Winterbourn; Anthony J Kettle
Journal:  J Biol Chem       Date:  2013-01-10       Impact factor: 5.157

3.  Lactoferrin Isolation Using Monolithic Column Coupled with Spectrometric or Micro-Amperometric Detector.

Authors:  Vojtech Adam; Ondrej Zitka; Petr Dolezal; Ladislav Zeman; Ales Horna; Jaromir Hubalek; Jan Sileny; Sona Krizkova; Libuse Trnkova; Rene Kizek
Journal:  Sensors (Basel)       Date:  2008-01-24       Impact factor: 3.576

4.  Fine Regulation of Neutrophil Oxidative Status and Apoptosis by Ceruloplasmin and Its Derivatives.

Authors:  Ekaterina A Golenkina; Galina M Viryasova; Svetlana I Galkina; Tatjana V Gaponova; Galina F Sud'ina; Alexey V Sokolov
Journal:  Cells       Date:  2018-01-12       Impact factor: 6.600

Review 5.  Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology.

Authors:  Zhidong Liu; Miao Wang; Chunbo Zhang; Shigao Zhou; Guang Ji
Journal:  Diabetes Metab Syndr Obes       Date:  2022-03-03       Impact factor: 3.168

6.  Caught red handed: modeling and confirmation of the myeloperoxidase ceruloplasmin alpha-thrombin complex.

Authors:  Yana A Zabrodskaya; Vladimir V Egorov; Alexey V Sokolov; Alexey V Shvetsov; Yulia E Gorshkova; Oleksandr I Ivankov; Valeria A Kostevich; Nikolay P Gorbunov; Edward S Ramsay; Natalya D Fedorova; Andrey B Bondarenko; Vadim B Vasilyev
Journal:  Biometals       Date:  2022-08-13       Impact factor: 3.378

7.  Ceruloplasmin: macromolecular assemblies with iron-containing acute phase proteins.

Authors:  Valeriya R Samygina; Alexey V Sokolov; Gleb Bourenkov; Maxim V Petoukhov; Maria O Pulina; Elena T Zakharova; Vadim B Vasilyev; Hans Bartunik; Dmitri I Svergun
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

Review 8.  Peroxidase Activity of Human Hemoproteins: Keeping the Fire under Control.

Authors:  Irina I Vlasova
Journal:  Molecules       Date:  2018-10-08       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.